"False"
Umeå universitet
printicon
Huvudmenyn dold.

Camilla Thellenberg Karlsson

Kontakt

E-post
camilla.thellenberg@umu.se
Telefon
090-785 28 59

Verksam vid

Anknytning
Adjungerad universitetslektor vid Institutionen för diagnostik och intervention Enhet: Onkologi
Plats
27C, Målpunkt QC31, NUS, Norrlands universitetssjukhus Umeå universitet, 901 85 Umeå
Histopathology-validated gross tumor volume delineations of intraprostatic lesions using PSMA-positron emission tomography/multiparametric magnetic resonance imaging
Physics and Imaging in Radiation Oncology, Elsevier 2024, Vol. 31
Grefve, Josefine; Söderkvist, Karin; Gunnlaugsson, Adalsteinn; et al.
Socioeconomic inequality in prostate cancer diagnostics, primary treatment, rehabilitation, and mortality in Sweden
International Journal of Cancer, John Wiley & Sons 2024, Vol. 155, (4) : 637-645
Strömberg, Ulf; Berglund, Anders; Carlsson, Stefan; et al.
Accuracy of gross tumour volume delineation with [68Ga]-PSMA-PET compared to histopathology for high-risk prostate cancer
Acta Oncologica, MJS Publishing, Medical Journals Sweden 2024, Vol. 63 : 503-510
Zarei, Maryam; Wallstén, Elin; Grefve, Josefine; et al.
Hyaluronic acid spacer in prostate cancer radiotherapy: dosimetric effects, spacer stability and long-term toxicity and PRO in a phase II study
Radiation Oncology, BioMed Central (BMC) 2023, Vol. 18, (1)
Björeland, Ulrika; Notstam, Kristina; Fransson, Per; et al.
Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden
Scandinavian journal of urology, Medical Journals Sweden 2023, Vol. 58 : 93-100
Gedeborg, Rolf; Sandin, Fredrik; Thellenberg-Karlsson, Camilla; et al.
The grade of individual prostate cancer lesions predicted by magnetic resonance imaging and positron emission tomography
Communications Medicine, Springer Nature 2023, Vol. 3, (1)
Nilsson, Erik; Sandgren, Kristina; Grefve, Josefine; et al.
Histopathology-validated lesion detection rates of clinically significant prostate cancer with mpMRI, [68Ga]PSMA-11-PET and [11C]Acetate-PET
Nuclear medicine communications, Lippincott Williams & Wilkins 2023, Vol. 44, (11) : 997-1004
Sandgren, Kristina; Strandberg, Sara; Jonsson, Joakim; et al.
Ki67 and prostate specific antigen are prognostic in metastatic hormone naïve prostate cancer
Acta Oncologica, Taylor & Francis 2023, Vol. 6212 : 1698-1706
Spyratou, Vasiliki; Freyhult, Eva; Bergh, Anders; et al.
A randomised, double-blind, dose-finding, phase II multicentre study of ODX in the treatment of patients with castration-resistant prostate cancer and skeletal metastases
European Journal of Cancer, Elsevier 2023, Vol. 181 : 198-207
Thellenberg-Karlsson, Camilla; Vjaters, Egils; Kase, Marju; et al.
Risk of severe late toxicity after radiotherapy following radical prostatectomy: a nationwide study
BJU International, John Wiley & Sons 2022, Vol. 130, (6) : 799-808
Braide, Karin; Kindblom, Jon; Thellenberg-Karlsson, Camilla; et al.
The Swedish national guidelines on prostate cancer, part 2: recurrent, metastatic and castration resistant disease
Scandinavian journal of urology, Taylor & Francis Group 2022, Vol. 56, (4) : 278-284
Bratt, Ola; Carlsson, Stefan; Fransson, Per; et al.
The Swedish national guidelines on prostate cancer, part 1: early detection, diagnostics, staging, patient support and primary management of non-metastatic disease
Scandinavian journal of urology, Taylor & Francis Group 2022, Vol. 56, (4) : 265-273
Bratt, Ola; Carlsson, Stefan; Fransson, Per; et al.
Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study
Acta Oncologica, Taylor & Francis 2022, Vol. 61, (3) : 328-332
Gedeborg, Rolf; Garmo, Hans; Thellenberg-Karlsson, Camilla; et al.
Characteristics of patients in SPCG-15: a randomized trial comparing radical prostatectomy with primary radiotherapy plus androgen deprivation therapy in men with locally advanced prostate cancer
European Urology Open Science, Elsevier BV 2022, Vol. 41 : 63-73
Gongora, Magdalena; Stranne, Johan; Johansson, Eva; et al.
Clinical and biological relevance of the transcriptomic-based prostate cancer metastasis subtypes MetA-C
Molecular Oncology, John Wiley & Sons 2022, (4)
Thysell, Elin; Köhn, Linda; Semenas, Julius; et al.
Epithelial and stromal characteristics of primary tumors predict the bone metastatic subtype of prostate cancer and patient survival after androgen-deprivation therapy
Cancers, MDPI 2022, Vol. 14, (21)
Wikström, Pernilla; Halin Bergström, Sofia; Josefsson, Andreas; et al.
Impact of neoadjuvant androgen deprivation therapy on magnetic resonance imaging features in prostate cancer before radiotherapy
Physics and Imaging in Radiation Oncology, Elsevier 2021, Vol. 17 : 117-123
Björeland, Ulrika; Nyholm, Tufve; Jonsson, Joakim; et al.
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial
The Lancet Oncology, Elsevier 2021, Vol. 22, (2) : 235-245
Fransson, Per; Nilsson, Per; Gunnlaugsson, Adalsteinn; et al.
Robust treatment planning of dose painting for prostate cancer based on ADC-to-Gleason score mappings: what is the potential to increase the tumor control probability?
Acta Oncologica, Taylor & Francis 2021, Vol. 60, (2) : 199-209
Gronlund, Eric; Almhagen, Erik; Johansson, Silvia; et al.
Deep learning-based classification and structure name standardization for organ at risk and target delineations in prostate cancer radiotherapy
Journal of Applied Clinical Medical Physics, John Wiley & Sons 2021, Vol. 22, (12) : 51-63
Jamtheim Gustafsson, Christian; Lempart, Michael; Swärd, Johan; et al.
Registration of histopathology to magnetic resonance imaging of prostate cancer
Physics and Imaging in Radiation Oncology, Elsevier 2021, Vol. 18 : 19-25
Sandgren, Kristina; Nilsson, Erik; Keeratijarut Lindberg, Angsana; et al.
COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial
Trials, BioMed Central 2021, Vol. 22, (1)
Welén, Karin; Överby, Anna K.; Ahlm, Clas; et al.
High monocyte count and expression of s100a9 and s100a12 in peripheral blood mononuclear cells are associated with poor outcome in patients with metastatic prostate cancer
Cancers, MDPI 2021, Vol. 13, (10)
Åberg, Anna-Maja; Halin Bergström, Sofia; Thysell, Elin; et al.
Assessing Radiographic Response to 223Ra with an Automated Bone Scan Index in Metastatic Castration-Resistant Prostate Cancer Patients
Journal of Nuclear Medicine, Society of Nuclear Medicine and Molecular Imaging 2020, Vol. 61, (5) : 671-675
Anand, Aseem; Tragardh, Elin; Edenbrandt, Lars; et al.
Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti-androgens
The Prostate, John Wiley & Sons 2020, Vol. 80, (2) : 214-224
Bovinder Ylitalo, Erik; Thysell, Elin; Thellenberg-Karlsson, Camilla; et al.
The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer
Trials, BioMed Central 2020, Vol. 21, (1)
Crippa, Alessio; De Laere, Bram; Discacciati, Andrea; et al.
A randomized phase III trial between adjuvant docetaxel and surveillance after radical radiotherapy (RT) for intermediate and high-risk prostate cancer (PC): Quality-of-life results (QoL) in SPCG-13 trial
Journal of Clinical Oncology, American Society of Clinical Oncology 2020, Vol. 38, (6)
Kellokumpu-Lehtinen, Pirkko-Liisa; Hjälm-Eriksson, Marie; Thellenberg-Karlsson, Camilla; et al.
Tumor-educated platelets for early prostate cancer diagnosis, and therapy stratification in patients with metastasized castration resistant prostate cancer
Clinical Cancer Research, American Association for Cancer Research 2020, Vol. 26, (11) : 73-74
Tjon-Kon-Fat, Lee-Ann; Köhn, Linda; Best, Myron; et al.
Improved PET/MRI attenuation correction in the pelvic region using a statistical decomposition method on T2-weighted images
EJNMMI Physics, Springer 2020, Vol. 7, (1)
Wallstén, Elin; Axelsson, Jan; Jonsson, Joakim; et al.
Editorial Comment: Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
International Brazilian Journal of Urology, Vol. 46, (6) : 1100-1101
Widmark, Anders; Gunnlaugsson, Adalsteinn; Beckman, Lars; et al.
Imaging for the Detection of Locoregional Recurrences in Biochemical Progression After Radical Prostatectomy: A Systematic Review
European Urology Focus, Elsevier 2019, Vol. 5, (4) : 550-560
Sandgren, Kristina; Westerlinck, Philippe; Jonsson, Joakim; et al.
Re-treatment with radium-223: 2-year follow-up from an international, open-label, phase 1/2 study in patients with castration-resistant prostate cancer and bone metastases
The Prostate, Wiley Periodicals 2019, Vol. 79, (14) : 1683-1691
Sartor, Oliver; Heinrich, Daniel; Mariados, Neil; et al.
PET/MRI attenuation correction in the pelvic region with a statistical decomposition method
European Journal of Nuclear Medicine and Molecular Imaging, Springer 2019, Vol. 46, (SUPPL 1) : S289-S290
Wallstén, Elin; Axelsson, Jan; Jonsson, Joakim; et al.
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
The Lancet, Elsevier 2019, Vol. 394, (10196) : 385-395
Widmark, Anders; Gunnlaugsson, Adalsteinn; Beckman, Lars; et al.
Quantifying the Effect of 3T Magnetic Resonance Imaging Residual System Distortions and Patient-Induced Susceptibility Distortions on Radiation Therapy Treatment Planning for Prostate Cancer
International Journal of Radiation Oncology, Biology, Physics, Elsevier 2018, Vol. 100, (2) : 317-324
Adjeiwaah, Mary; Bylund, Mikael; Lundman, Josef A.; et al.
Inter-fraction movements of the prostate and pelvic lymph nodes during IGRT
Journal of radiation oncology, Springer 2018, Vol. 7, (4) : 357-366
Björeland, Ulrika; Jonsson, Joakim; Alm, Magnus; et al.
U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden
Acta Oncologica, Taylor & Francis 2018, Vol. 57, (2) : 187-194
Glimelius, Bengt; Melin, Beatrice; Enblad, Gunilla; et al.
Dose painting of prostate cancer based on Gleason score correlations with apparent diffusion coefficients
Acta Oncologica, Vol. 57, (5) : 574-581
Gronlund, Eric; Johansson, Silvia; Nyholm, Tufve; et al.
Platelets harbor prostate cancer biomarkers and the ability to predict therapeutic response to abiraterone in castration resistant patients
The Prostate, Wiley-Blackwell 2018, Vol. 78, (1) : 48-53
Tjon-Kon-Fat, Lee-Ann; Lundholm, Marie; Schröder, Mona; et al.
Ultrahypofractionation for prostate cancer: Outcome from the Scandinavian phase 3 HYPO-RT-PC trial
Radiotherapy and Oncology, Elsevier 2018, Vol. 127 : S314-S314
Widmark, Anders; Gunnlaugsson, A.; Beckman, Lars; et al.
Cabazitaxel followed by androgen deprivation therapy (ADT) significantly improves time to progression in patients with newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC): A randomized, open label, phase III, multicenter trial
Annals of Oncology, Elsevier 2017, Vol. 28, (S5) : v281-v281
Andren, O.; Widmark, Anders; Falt, A.; et al.
Haralick texture features from apparent diffusion coefficient (ADC) MRI images depend on imaging and pre-processing parameters
Scientific Reports, Nature Publishing Group 2017, Vol. 7
Brynolfsson, Patrik; Nilsson, David; Torheim, Turid; et al.
Patient-induced susceptibility effects simulation in magnetic resonance imaging
Physics and Imaging in Radiation Oncology, Elsevier 2017, Vol. 1 : 41-45
Lundman, Josef Axel; Bylund, Mikael; Garpebring, Anders; et al.
Re-treatment with radium-223: first experience from an international, open-label, phase I/II study in patients with castration-resistant prostate cancer and bone metastases
Annals of Oncology, OXFORD UNIV PRESS 2017, Vol. 28, (10) : 2464-2471
Sartor, O.; Heinrich, D.; Mariados, N.; et al.
Analysis of overall survival by number of radium-223 injections received in an international expanded access program (iEAP)
Oncology Research and Treatment, S. Karger 2017, Vol. 40 : 320-320
Wirth, M.; Saad, F.; Keizman, D.; et al.
Long-term adverse effects after curative radiotherapy and radical prostatectomy: population-based nationwide register study
Scandinavian journal of urology, Vol. 50, (5) : 338-345
Fridriksson, Jón O.; Folkvaljon, Yasin; Nilsson, Per; et al.
Bone Scan Index as an Imaging Biomarker in Metastatic Castration-resistant Prostate Cancer: A Multicentre Study Based on Patients Treated with Abiraterone Acetate (Zytiga) in Clinical Practice
European Urology Focus, Elsevier 2016, Vol. 2, (5) : 540-546
Reza, Mariana; Ohlsson, Mattias; Kaboteh, Reza; et al.
Re-treatment of Radium-223 From an International, Multicenter, Prospective, Single-Arm Trial in Patients With Castration-Resistant Prostate Cancer and Bone Metastases
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 43 : S104-S104
Schwartz, A.; Sartor, O.; Mariados, N.; et al.
C-11-Acetate-PET/CT Compared to Tc-99m-HDP Bone Scintigraphy in Primary Staging of High-risk Prostate Cancer
Anticancer Research, International Institute of Anticancer Research 2016, Vol. 36, (12) : 6475-6479
Strandberg, Sara; Karlsson, Camilla Thellenberg; Ögren, Mattias; et al.
Bone-targeted Novel Cytotoxic Polybisphosphonate Conjugate in Castration-resistant Prostate Cancer: A Multicenter Phase 1 Study
Anticancer Research, International Institute of Anticancer Research 2016, Vol. 36, (12) : 6499-6504
Thellenberg-Karlsson, Camilla; Nyman, Claes; Nilsson, Sten; et al.
Visa publikationer i DiVA